Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.250
-0.230-4.20%
Volume:72.16M
Turnover:381.46M
Market Cap:98.09B
PE:34.58
High:5.480
Open:5.480
Low:5.235
Close:5.480
52wk High:8.647
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.82
T/O Rate:0.39%
Dividend:0.12
Dividend Rate:2.29%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.57
PE(LYR):34.58
PS:2.49

Loading ...

Sino Biopharm Secures Deal to Up Stake in CT Tianqing

MT Newswires Live
·
Sep 11

Sino Biopharmaceutical - Sbp Group to Buy 5% Equity Interest in Ct Tianqing for Rmb4.48 Bln at 19X Ltm P/E

THOMSON REUTERS
·
Sep 11

Movement Alert|SBP GROUP Falls 3.19% in Regular Trading, Trading at HK$5.3

Market Focus
·
Sep 11

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Movement Alert|SBP GROUP Declines 3.08% in Regular Trading, Trading at 5.67 HKD

Market Focus
·
Sep 09

SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026

Stock News
·
Sep 08

Sino Biopharm Presents ERS 2026 Preclinical Data for Oral STAT6 Degrader Tqh5528

Reuters
·
Sep 08

Sino Biopharm CEO Tse Says AI, Internationalization Anchor Counter-Cyclical Growth Strategy

Reuters
·
Sep 08

Movement Alert|SBP GROUP Rises 3.02% in Regular Trading, TQC3721 Inhaler Phase I Clinical Data Presented at European Respiratory Society Annual Meeting

Market Focus
·
Sep 08

Hong Kong Stock Market Update | SBP GROUP (01177) Climbs Nearly 3% After TQC3721 Inhalation Powder Data Presented at ERS 2026

Stock News
·
Sep 08

SBP Group Unveils Positive Phase I Data for TQC3721 Dry-Powder Inhaler at ERS 2026

Bulletin Express
·
Sep 07

Sino Biopharma Reports Phase I Data Showing Tqc3721 Dry Powder Inhaler Boosts COPD Lung Function in Dose-Ranging Trial

Reuters
·
Sep 07

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 07

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Reuters
·
Sep 04

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live
·
Sep 04

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

Reuters
·
Sep 03

Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 "Gpc3 ADC" Approved by FDA

THOMSON REUTERS
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03